Iceland· IS-EU/1/17/1238/001

Nyxoid

A naloxone product containing naloxonum inn hýdróklóríð, registered in Iceland by Mundipharma Corporation (Ireland) Limited. The same ATC class is registered in 11 of our 19 countries.

ATC V03AB15

Checked against Icelandic Medicines Agency (Iceland) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about naloxonum inn hýdróklóríðAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Naloxone is registered in 11 of 19 countries.

Countries holding a registration under ATC V03AB15 (naloxone), each read from that country’s own register.

This record: Iceland, from Icelandic Medicines Agency (Iceland)
7 of them publish a price we can compare per daily dose

Search naloxone products by name

Naloxone · ATC V03AB15

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)

Active substance: Naloxonum INN hýdróklóríð
Manufacturer: Mundipharma Corporation (Ireland) Limited
Country: Iceland (IS)
ATC code: V03AB15
ATC class: Naloxone
Reimbursed: Not published by this register
Source register: Icelandic Medicines Agency (Iceland)
Last checked: September 29, 2026

Packs & prices · 1

1 priced

ean
461563
0,1 ml x2 stsk.í
ISK 8119

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

104 interactions on record for naloxone.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check naloxone against other medicines How interaction checks work

Naloxone · interactions on record

104 records

2 severe
34 moderate
4 minor
64 info

Most severe, free to view

DroperidolN01AX01severe
DroperidolN05AD08severe
Methylnaltrexone bromideA06AH01moderate
NaloxegolA06AH03moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Naloxone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naloxone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Forvel, Naloxon Accord
Belgium · Naloxon B. Braun
Bulgaria · Форвел
Cyprus · Codaxol, Forvel
Czechia · Forvel, Naloxone Polpharma
Germany · Naloxon Accord, Naloxon B. Braun
Denmark · Forvel, Naloxon B. Braun
Estonia · Forvel, Ventizolve
Spain · Fomed, Naloxona B. Braun
Finland · Naloxone Accord, Nexodal
France · Naloxone Accord, Naloxone Adapt Pharma
United Kingdom (Northern Ireland) · Naloxone Accord-Uk, Naloxone B. Braun Melsungen
Greece · Forvel, Νaloxon B.Braun
Croatia · Forvel
Hungary · Nexodal
Ireland · Naloxone Hydrochloride Accord, Naloxone Hydrochloride Mercury Pharmaceuticals (Ireland)
Italy · Naloxone Accord, Naloxone Adapt
Liechtenstein · Nyxoid
Lithuania · Forvel
Luxembourg · Naloxon B. Braun
Latvia · Forvel
Malta · Forvel
Netherlands · Naloxon Hci B. Braun, Naloxon Hcl Accord
Norway · Naloxon B. Braun, Naloxon Hameln
Poland · Naloxonum Hydrochloricum Wzf
Portugal · Forvel, Naloxona Accord
Romania · Forvel
Sweden · Naloxon Actrevo, Naloxon Hameln
Slovenia · Nexodal
Slovakia · Naloxone Polpharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/75929c9b-3c9d-4b16-a7d1-497fec1b0b1c
GET /v1/drugs/75929c9b-3c9d-4b16-a7d1-497fec1b0b1c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nefúði, lausn í stakskammtaíláti",
  "source": "lyfjastofnun",
  "atc_raw": "V03AB15",
  "marketed": true,
  "strength": "1,8 mg",
  "ma_number": "EU/1/17/1238/001",
  "substance": "Naloxonum INN hýdróklóríð",
  "other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "43049"
}

API reference MCP server Plans

See everything about naloxone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console